Electromed, Inc. (ELMD)
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
$28.00+1.41%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · ELMD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 73.8 | 73.8 | 64.0 | 54.7 | 48.1 | 41.7 | 35.8 | 32.5 | 31.3 | 28.3 | 25.9 | 23.0 | 19.4 | 15.5 | 15.1 | 19.5 |
| Total Revenues | — | — | — | 54.7 | 48.1 | 41.7 | 35.8 | 32.5 | 31.3 | 28.3 | 25.9 | 23.0 | 19.4 | 15.5 | 15.1 | 19.5 |
| Cost of Revenues | 15.8 | 15.8 | 14.0 | 13.0 | 11.5 | 10.2 | 8.5 | 7.3 | 7.5 | 6.5 | 5.3 | 5.1 | 5.8 | 4.9 | 4.7 | 5.4 |
| Gross Profit | 57.9 | 57.9 | 50.0 | 41.7 | 36.5 | 31.4 | 27.3 | 25.2 | 23.8 | 21.8 | 20.6 | 17.9 | 13.6 | 10.6 | 10.4 | 14.1 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 42.7 | 42.7 | 39.3 | 34.5 | 31.6 | 27.1 | 22.4 | 19.9 | 20.4 | 18.8 | 16.4 | 14.4 | 12.0 | 10.9 | 11.7 | 12.6 |
| R&D Expenses | 1.3 | 1.3 | 1.0 | 0.7 | 0.9 | 1.4 | 1.7 | 1.1 | 0.6 | 0.3 | 0.6 | 0.4 | 0.3 | 0.5 | 0.6 | 0.9 |
| Operating Income | 13.9 | 13.9 | 9.7 | 6.6 | 4.0 | 3.0 | 3.1 | 5.1 | 2.8 | 2.7 | 3.6 | 3.1 | 1.3 | (0.7) | (1.8) | 0.6 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | 0.1 | 0.1 | 0.1 | 0.2 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | 0.1 | 0.1 | 0.1 | 0.2 |
| EBT, Incl. Unusual Items | 14.4 | 14.4 | 10.3 | 7.0 | 4.1 | 3.0 | 3.2 | 5.2 | 2.9 | 2.7 | 3.5 | 3.0 | 1.2 | (0.8) | (1.9) | 0.4 |
| Income Tax Expense | 3.1 | 3.1 | 2.7 | 1.9 | 0.9 | 0.7 | 0.8 | 1.1 | 0.9 | 0.9 | 1.3 | 0.8 | 0.1 | 0.5 | (0.6) | 0.3 |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | — | — | — | — | — | 1.1 | (1.3) | (1.3) | 0.2 |
| Net Income | ||||||||||||||||
| Net Income | 11.3 | 11.3 | 7.5 | 5.2 | 3.2 | 2.3 | 2.4 | 4.2 | 2.0 | 1.8 | 2.2 | 2.2 | 1.1 | (1.3) | (1.3) | 0.2 |
| Per Share | ||||||||||||||||
| Basic EPS | — | 1.37 | 0.89 | 0.60 | 0.37 | 0.27 | 0.28 | 0.50 | 0.24 | 0.22 | 0.27 | 0.27 | 0.13 | — | — | 0.02 |
| Diluted EPS | — | 1.30 | 0.85 | 0.58 | 0.36 | 0.26 | 0.27 | 0.47 | 0.23 | 0.21 | 0.26 | 0.27 | 0.13 | — | — | 0.02 |
| Basic Weighted Avg Shares | — | 8.3 | 8.5 | 8.6 | 8.5 | 8.5 | 8.6 | 8.4 | 8.3 | 8.2 | 8.2 | 8.1 | 8.1 | 8.1 | 8.1 | 8.1 |
| Diluted Weighted Avg Shares | — | 8.7 | 8.9 | 8.9 | 8.7 | 8.8 | 8.9 | 8.8 | 8.6 | 8.6 | 8.5 | 8.2 | 8.2 | 8.1 | 8.1 | 8.1 |
| Supplemental | ||||||||||||||||
| EBIT | 13.9 | 13.9 | 9.7 | 6.6 | 4.0 | 3.0 | 3.1 | 5.1 | 2.8 | 2.7 | 3.6 | 3.1 | 1.3 | (0.7) | (1.8) | 0.6 |
| Effective Tax Rate | 21.3% | — | — | — | 22.5% | 23.1% | 25.4% | 20.6% | 32.2% | 33.0% | 36.7% | 27.3% | 10.8% | -57.2% | 31.6% | 57.4% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.